Investigating genetic factors that contribute to osteoarthritis
Functional interrogation of putative osteoarthritis causal variants
This study is looking at how certain genes might play a role in osteoarthritis, helping us understand what causes the condition and how we might be able to prevent or slow it down in the future.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11059233 on NIH RePORTER |
What this research studies
This research aims to understand the genetic mechanisms behind osteoarthritis (OA) by examining specific genetic variants that may influence the disease. Researchers will analyze how these variants affect gene expression in cartilage cells, using advanced techniques to assess their impact under normal and stimulated conditions. By identifying which genetic factors are most likely to cause OA, the study seeks to pave the way for early intervention strategies that could prevent or mitigate the disease's progression.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for osteoarthritis, particularly those with a family history of the disease or genetic predispositions.
Not a fit: Patients who are already diagnosed with advanced osteoarthritis or those with other joint diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating osteoarthritis, potentially reducing disability and improving quality of life for patients.
How similar studies have performed: Previous research has successfully identified genetic variants associated with osteoarthritis, suggesting that this approach has the potential for meaningful insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Diekman, Brian O — Univ of North Carolina Chapel Hill
- Study coordinator: Diekman, Brian O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.